Hematologic toxicity
Showing 1 - 25 of 8,967
Integrated Chinese Medicine With Western Medicine for Reduction
Completed
- Myelosuppression
- Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment
- (no location specified)
Jun 28, 2022
Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed
Completed
- Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
- pemetrexed-related hematological toxicity
-
Reims, FranceChu Reims
Feb 11, 2022
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Solid Tumor, Adult, Solid Tumor, Childhood, Hematologic Cancer Trial in Villejuif (Tumor biopsy, Blood sample, Bone marrow
Recruiting
- Solid Tumor, Adult
- +2 more
- Tumor biopsy
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy Cancer Campus Grand Paris
Jul 28, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Total-Body Irradiation
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
Toxicity inHaematological Malignancy Treated With Immunotherapy.
Recruiting
- Blood Cancer
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Hematological Malignancies Trial in Boston, Durham (Pasireotide)
Completed
- Hematological Malignancies
-
Boston, Massachusetts
- +1 more
Oct 19, 2021
Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- busulfan
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute at Universit
Dec 9, 2020
Methods in Newly Diagnosed Multiple Myeloma Patients
Completed
- Multiple Myeloma
- Hematologic Diseases
-
Antwerpen, Belgium
- +19 more
May 3, 2021
Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)
Not yet recruiting
- Ovarian Cancer
- +3 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jul 18, 2023
Intestinal, Haematological and Urinary Toxicity From Pelvic
Active, not recruiting
- Prostate Cancer
-
Milan, ItalyIRCCS San Raffaele
Jan 4, 2023
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Duarte, Rochester, Columbus (Best Practice, Biospecimen
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage III Lung Cancer AJCC v8
- Best Practice
- +5 more
-
Duarte, California
- +2 more
Nov 14, 2023
Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)
Completed
- Cervical Carcinoma
- Intensity Modulated Radiation Therapy (IMRT)
- +2 more
-
La Jolla, CaliforniaMoores UC San Diego Cancer Center
Feb 16, 2022
Ovarian Cancer, Chemotherapeutic Toxicity Trial in Evanston (Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin,
Not yet recruiting
- Ovarian Cancer
- Chemotherapeutic Toxicity
- Fasting Mimicking Diet (Xentigen by L'Nutra)
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Jun 25, 2023
Prevelance Of Cutaneous Disorders Among Heamatologic
Not yet recruiting
- Dermatologic Disorders With Heamatologic Malignancies Patients
- cbc ,u\s renalor hepatic function test if needed
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)
Active, not recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- Thymoglobulin
- +7 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 20, 2021
Rectal Cancer Trial in Stockholm (Radiation therapy)
Recruiting
- Rectal Cancer
- Radiation therapy
-
Stockholm, Solna, SwedenKarolinska University Hospital, Theme Cancer, Dept of Pelvic can
Aug 15, 2022
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Biology of Long-Term Late Effects Following Hematopoietic Cell
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
-
Scottsdale, Arizona
- +31 more
Mar 8, 2022
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)
Recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Cholestyramine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 5, 2023
Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)
Not yet recruiting
- Ovarian Cancer
- Malignant Neoplasm of Uterus
-
New York, New YorkIcahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023
T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)
Not yet recruiting
- T-Cell Non-Hodgkin Lymphoma
- +14 more
- WU-CART-007
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer Trial in Pierre-Bénite
Recruiting
- Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
- Pharmacokinetics, Dosage of Niraparib
-
Pierre-Bénite, FranceHôpital Lyon sud, Institut de Cancérologie des Hospices Civils d
Apr 19, 2022